Erectile Dysfunction Drugs Market Size, Share, Analysis, Trends, Growth, 2028

Erectile Dysfunction Drugs Market

Erectile Dysfunction Drugs Market By Therapeutics (Existing drugs, Tadalafil, Sildenafil Citrate Vardenafil, Udenafil, Stendra/Spedra, Lodenafil Carbonate, Mirodenafil Pipeline drugs, Apomorphine, Alprostadil, Topiglan, Gene Therapy, and Melanocortin Activators), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022-2028

Category: Pharmaceutical Report Format : PDF Pages: 190 Report Code: ZMR-3395 Published Date: May-2022 Status : Published
Market Size in 2021 Market Forecast in 2028 CAGR (in %) Base Year
USD 3.64 Billion USD 5.94 Billion 6.9% 2021

Erectile Dysfunction Drugs Market

Request For Customization Request Free Sample Buy Now

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Erectile Dysfunction Drugs Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Erectile Dysfunction Drugs Market : snapshot
  • Chapter 3. Global Erectile Dysfunction Drugs Market - Industry Analysis
    • 3.1 Erectile Dysfunction Drugs Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growth in embracing poor lifestyle choices may boost the market growth over the forecast period.
    • 3.3 Market Restraints
      • 3.3.1. Low awareness and side effects associated with erectile dysfunction drugs may hinder the market growth.
    • 3.4 Market Opportunities
      • 3.4.1. Increased pharmaceutical manufacturing in emerging countries is likely to offer better growth opportunities for market expansion.
    • 3.5 Market Challenges
      • 3.5.1. An increase in the availability of counterfeit erectile dysfunction medicines poses a major challenge to the market expansion.
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Therapeutics
  • Chapter 4. Global Erectile Dysfunction Drugs Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Erectile Dysfunction Drugs Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Erectile Dysfunction Drugs Market - Therapeutics Analysis
    • 5.1 Global Erectile Dysfunction Drugs Market overview: By Therapeutics
      • 5.1.1 Global Erectile Dysfunction Drugs Market share, By Therapeutics, 2021 and 2028
    • 5.2 Existing drugs
      • 5.2.1 Global Erectile Dysfunction Drugs Market by Existing drugs, 2022 - 2028 (USD Billion)
    • 5.3 Tadalafil
      • 5.3.1 Global Erectile Dysfunction Drugs Market by Tadalafil, 2022 - 2028 (USD Billion)
    • 5.4 Sildenafil Citrate Vardenafil
      • 5.4.1 Global Erectile Dysfunction Drugs Market by Sildenafil Citrate Vardenafil, 2022 - 2028 (USD Billion)
    • 5.5 Udenafil
      • 5.5.1 Global Erectile Dysfunction Drugs Market by Udenafil, 2022 - 2028 (USD Billion)
    • 5.6 Stendra/Spedra
      • 5.6.1 Global Erectile Dysfunction Drugs Market by Stendra/Spedra, 2022 - 2028 (USD Billion)
    • 5.7 Lodenafil Carbonate
      • 5.7.1 Global Erectile Dysfunction Drugs Market by Lodenafil Carbonate, 2022 - 2028 (USD Billion)
    • 5.8 Mirodenafil Pipeline drugs
      • 5.8.1 Global Erectile Dysfunction Drugs Market by Mirodenafil Pipeline drugs, 2022 - 2028 (USD Billion)
    • 5.9 Apomorphine
      • 5.9.1 Global Erectile Dysfunction Drugs Market by Apomorphine, 2022 - 2028 (USD Billion)
    • 5.10 Alprostadil
      • 5.10.1 Global Erectile Dysfunction Drugs Market by Alprostadil, 2022 - 2028 (USD Billion)
    • 5.11 Topiglan
      • 5.11.1 Global Erectile Dysfunction Drugs Market by Topiglan, 2022 - 2028 (USD Billion)
    • 5.12 Gene Therapy
      • 5.12.1 Global Erectile Dysfunction Drugs Market by Gene Therapy, 2022 - 2028 (USD Billion)
    • 5.13 Melanocortin Activators
      • 5.13.1 Global Erectile Dysfunction Drugs Market by Melanocortin Activators, 2022 - 2028 (USD Billion)
  • Chapter 6. Erectile Dysfunction Drugs Market - Regional Analysis
    • 6.1 Global Erectile Dysfunction Drugs Market Regional Overview
    • 6.2 Global Erectile Dysfunction Drugs Market Share, by Region, 2021 & 2028 (USD Billion)
    • 6.3. North America
      • 6.3.1 North America Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
        • 6.3.1.1 North America Erectile Dysfunction Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 6.4 North America Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028
      • 6.4.1 North America Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028 (USD Billion)
    • 6.4. Europe
      • 6.4.2 Europe Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
        • 6.4.2.1 Europe Erectile Dysfunction Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 6.4 Europe Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028
      • 6.4.1 Europe Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028 (USD Billion)
    • 6.5. Asia Pacific
      • 6.5.3 Asia Pacific Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
        • 6.5.3.1 Asia Pacific Erectile Dysfunction Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 6.4 Asia Pacific Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028
      • 6.4.1 Asia Pacific Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028 (USD Billion)
    • 6.6. Latin America
      • 6.6.4 Latin America Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
        • 6.6.4.1 Latin America Erectile Dysfunction Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 6.4 Latin America Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028
      • 6.4.1 Latin America Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028 (USD Billion)
    • 6.7. The Middle-East and Africa
      • 6.7.5 The Middle-East and Africa Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
        • 6.7.5.1 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Country, 2022 - 2028 (USD Billion)
    • 6.4 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028
      • 6.4.1 The Middle-East and Africa Erectile Dysfunction Drugs Market, by Therapeutics, 2022 - 2028 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1 Eli Lilly & Co.
      • 7.1.1 Overview
      • 7.1.2 Financials
      • 7.1.3 Product Portfolio
      • 7.1.4 Business Strategy
      • 7.1.5 Recent Developments
    • 7.2 Pfizer
      • 7.2.1 Overview
      • 7.2.2 Financials
      • 7.2.3 Product Portfolio
      • 7.2.4 Business Strategy
      • 7.2.5 Recent Developments
    • 7.3 Dong-A Pharmaceutical Co. Ltd
      • 7.3.1 Overview
      • 7.3.2 Financials
      • 7.3.3 Product Portfolio
      • 7.3.4 Business Strategy
      • 7.3.5 Recent Developments
    • 7.4 Bayer AG
      • 7.4.1 Overview
      • 7.4.2 Financials
      • 7.4.3 Product Portfolio
      • 7.4.4 Business Strategy
      • 7.4.5 Recent Developments
    • 7.5 Meda Pharmaceuticals
      • 7.5.1 Overview
      • 7.5.2 Financials
      • 7.5.3 Product Portfolio
      • 7.5.4 Business Strategy
      • 7.5.5 Recent Developments
    • 7.6 Vivus Inc.
      • 7.6.1 Overview
      • 7.6.2 Financials
      • 7.6.3 Product Portfolio
      • 7.6.4 Business Strategy
      • 7.6.5 Recent Developments
    • 7.7 Apricus Biosciences.
      • 7.7.1 Overview
      • 7.7.2 Financials
      • 7.7.3 Product Portfolio
      • 7.7.4 Business Strategy
      • 7.7.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Erectile Dysfunction Drugs Market attractiveness, By Therapeutics
  • 6. Global Erectile Dysfunction Drugs Market share by Therapeutics, 2022 and 2028 (USD Billion)
  • 7. Global Erectile Dysfunction Drugs Market by Existing drugs, 2022 - 2028 (USD Billion)
  • 8. Global Erectile Dysfunction Drugs Market by Tadalafil, 2022 - 2028 (USD Billion)
  • 9. Global Erectile Dysfunction Drugs Market by Sildenafil Citrate Vardenafil, 2022 - 2028 (USD Billion)
  • 10. Global Erectile Dysfunction Drugs Market by Udenafil, 2022 - 2028 (USD Billion)
  • 11. Global Erectile Dysfunction Drugs Market by Stendra/Spedra, 2022 - 2028 (USD Billion)
  • 12. Global Erectile Dysfunction Drugs Market by Lodenafil Carbonate, 2022 - 2028 (USD Billion)
  • 13. Global Erectile Dysfunction Drugs Market by Mirodenafil Pipeline drugs, 2022 - 2028 (USD Billion)
  • 14. Global Erectile Dysfunction Drugs Market by Apomorphine, 2022 - 2028 (USD Billion)
  • 15. Global Erectile Dysfunction Drugs Market by Alprostadil, 2022 - 2028 (USD Billion)
  • 16. Global Erectile Dysfunction Drugs Market by Topiglan, 2022 - 2028 (USD Billion)
  • 17. Global Erectile Dysfunction Drugs Market by Gene Therapy, 2022 - 2028 (USD Billion)
  • 18. Global Erectile Dysfunction Drugs Market by Melanocortin Activators, 2022 - 2028 (USD Billion)
  • 19. Global Erectile Dysfunction Drugs Market share, by Region, 2022 and 2028
  • 20. North America Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
  • 21. Europe Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
  • 22. Asia Pacific Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
  • 23. Latin America Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)
  • 24. The Middle-East and Africa Erectile Dysfunction Drugs Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Erectile Dysfunction Drugs Market: Snapshot
  • 2. Drivers of the Erectile Dysfunction Drugs Market: impact analysis
  • 3. North America Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 4. U.S. Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 5. Canada Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 6. Europe Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 7. Germany Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 8. France Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 9. U.K. Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 10. Italy Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 11. Spain Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 12. Rest of Europe Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 13. Asia Pacific Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 14. China Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 15. Japan Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 16. India Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 17. South Korea Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 18. South-East Asia Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 19. Rest of Asia Pacific Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 20. Latin America Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 21. Brazil Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 22. Mexico Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 23. Rest of Latin America Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 24. The Middle-East and Africa Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 25. GCC Countries Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 26. South Africa Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)
  • 27. Rest of Middle-East Africa Erectile Dysfunction Drugs Market revenue, By Therapeutics, 2022 - 2028 (USD Billion)

Methodology

FrequentlyAsked Questions

With the surge in the adoption of a bad lifestyle, diabetes, obesity, and cardiovascular disease are on the rise, which in turn leads to problems like ED as people become older. The present lifestyle of youth in many emerging countries is very stressful that resulting in increased alcoholism, smoking, and fast food or ready-to-eat food consumption. Due to these factors, overall health and fitness are getting compromised which in turn increases the chances of ED. Furthermore, as the senior population grows, so does the number of ED patients, which is a significant driver of the global erectile dysfunction drugs market throughout the projection period.

According to the Zion Market Research report, the global erectile dysfunction drugs market was worth about 3.64 (USD billion) in 2021 and is predicted to grow to around 5.94 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 6.9 percent.

North America is likely to dominate the global erectile dysfunction drugs market. This is mainly due to the expanding senior population and superior healthcare infrastructure, as per a Rural Health Information Center report released in April 2019 stated that there are more than 46 million older persons in the United States, with that figure predicted to climb to about 90 million by 2050. When the last of the baby boom cohorts reach 65, the number of older individuals is predicted to climb by roughly 18 million between 2020 and 2030. Because ED is particularly frequent in men over the age of 40, the rise in the elderly male population is predicted to increase the number of individuals suffering from it.

Major players operating in the global erectile dysfunction drugs market include Eli Lilly & Co., Pfizer, Dong-A Pharmaceutical Co. Ltd, Bayer AG, Meda Pharmaceuticals, Vivus, Inc., and Apricus Biosciences.

Choose License Type

  • zion payment modes

List of Contents

Industry Prospective:OverviewGrowth DriversRestraintsOpportunitiesReport ScopeChallenges.An increase in the availability of counterfeit erectile dysfunction medicines poses a major challenge to the market expansion.SegmentationRecent DevelopmentsRegional LandscapeCompetitive Landscape Global erectile dysfunction drugs market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed